Digital spatial profiling of the microenvironment of muscle invasive bladder cancer
Name:
Digital spatial....pdf
Size:
5.369Mb
Format:
PDF
Description:
Found with Open Access Button
Authors
Eyers, M.Irlam, Joely
Marshall, G.
Smith, Vicky
Baker, Alexander
Frost, L.
Hoskin, Peter
Choudhury, Ananya
West, Catharine
Affiliation
Division of Cancer Sciences, University of Manchester, Manchester, UK; CRUK Manchester Centre, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK;Issue Date
2024
Metadata
Show full item recordAbstract
Muscle invasive bladder cancer (MIBC) is a molecularly diverse disease with varied clinical outcomes. Molecular studies typically employ bulk sequencing analysis, giving a transcriptomic snapshot of a section of the tumour. However, tumour tissues are not homogeneous, but are composed of distinct compartments such as the tumour and stroma. To investigate the molecular profiles of bladder cancer, whilst also maintaining the spatial complexity of the tumours, we employed whole transcriptome Digital Spatial Profiling (DSP). With this method we generated a dataset of transcriptomic profiles of tumour epithelium, stroma, and immune infiltrate. With these data we investigate the spatial relationship of molecular subtype signatures and ligand signalling events. We find that Basal/Squamous and Classical subtypes are mostly restricted to tumour regions, while the stroma-rich subtype signatures are abundant within the stroma itself. Additionally, we identify ligand signalling events occurring between tumour, stroma, and immune infiltrate regions, such as immune infiltrate derived GPNMB, which was highly correlated with VEGFA expression within the tumour. These findings give us new insights into the diversity of MIBC at a molecular level and provide a dataset with detailed spatial information that was not available before in bladder cancer research. A spatial transcriptomics study in bladder cancer investigates the spatial localization of molecular subtype signatures and ligand signaling events.Citation
Eyers M, Irlam J, Marshall G, Smith V, Baker A, Frost L, et al. Digital spatial profiling of the microenvironment of muscle invasive bladder cancer. Communications biology. 2024 JUN 18;7(1).Journal
Communications BiologyDOI
10.1038/s42003-024-06426-9PubMed ID
38890455Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s42003-024-06426-9
Scopus Count
Collections
Related articles
- Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis.
- Authors: Feng C, Wang Y, Song W, Liu T, Mo H, Liu H, Wu S, Qin Z, Wang Z, Tao Y, He L, Tang S, Xie Y, Wang Q, Li T
- Issue date: 2024
- Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer.
- Authors: Wang Y, Song W, Feng C, Wu S, Qin Z, Liu T, Ye Y, Huang R, Xie Y, Tang Z, Wang Q, Li T
- Issue date: 2024 Oct 4
- Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment.
- Authors: Dinh TJ, Rogg M, Cosenza-Contreras M, Li M, Zirngibl M, Pinter N, Kurowski K, Hause F, Pauli L, Imberg F, Huynh A, Schmid M, Glavinsky I, Braun L, Van Wymersch C, Bergmann L, Ungefug X, Kunz M, Werner T, Bernhard P, Espadas G, Brombacher E, Schueler J, Sabido E, Kreutz C, Gratzke C, Werner M, Grabbert M, Bronsert P, Schell C, Schilling O
- Issue date: 2025 Jan
- Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.
- Authors: Efstathiou JA, Mouw KW, Gibb EA, Liu Y, Wu CL, Drumm MR, da Costa JB, du Plessis M, Wang NQ, Davicioni E, Feng FY, Seiler R, Black PC, Shipley WU, Miyamoto DT
- Issue date: 2019 Jul
- Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
- Authors: Hovelson DH, Udager AM, McDaniel AS, Grivas P, Palmbos P, Tamura S, Lazo de la Vega L, Palapattu G, Veeneman B, El-Sawy L, Sadis SE, Morgan TM, Montgomery JS, Weizer AZ, Day KC, Neamati N, Liebert M, Keller ET, Day ML, Mehra R, Tomlins SA
- Issue date: 2018 Dec